NeuroWell [https://neurowell.ai/lander], an AI-powered mental health platform founded by a student-researcher, is now starting to roll out its public version after successful closed beta testing. They are partnering with select high schools to pilot the next generation of mental health screening and sentiment analysis for teenagers.
Grounded in clinical science and real student experiences, NeuroWell offers daily mental health check-ins using validated assessments like PHQ-9 and GAD-7, alongside AI-driven journal sentiment analysis powered by large language models (LLMs). The platform is designed to help schools detect early signs of depression, anxiety, and emotional distress-before a crisis emerges.
“As a student, I’ve seen how mental health struggles go unnoticed until it’s too late. NeuroWell [https://neurowell.ai/lander%5Dbridges that gap-giving students a private, science-backed tool while empowering schools with data-driven support systems,” said Aki Tanaka, Founder of NeuroWell.
How It Works
* Students complete validated screeners and journal entries through a secure web platform.
* AI analyzes mental health signals, combining clinical scores with language sentiment.
* Personalized nudges and anonymized dashboards help counselors take early, informed action.
Built For Schools, By Students
– Anonymized School Dashboard: Real-time, privacy-first insights for counselors
– HIPAA/FERPA-Compliant: Built to meet strict education and healthcare privacy standards
– No App Required: Accessible across devices, with offline-first flexibility
– Culturally-Aware Design: Adaptable tone and nudges for global student contexts
For media inquiries please contact at:
neurowellhq@gmail.com [mailto:neurowellhq@gmail.com]
Media Contact
Company Name: NeuroWell
Contact Person: Aki Tanaka – Founder, NeuroWell
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=studentled-startup-neurowell-expands-rollout-to-revolutionize-mental-health-screening-for-students]
Country: United States
Website: https://neurowell.ai/lander
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
